Is it a good stock to buy? So, PE alone cannot determine which is a good or bad stock. Indus Towers Limited has informed the Exchange regarding disclosure under Regulation 30 of SEBI (Listing ...

Shares of Vodafone Idea Ltd. and Indus Towers Ltd. are among the worst performing stocks on the Nifty 500 index on Wednesday, March 12. While shares of Indus Towers are down 7%, those of Vodafone Idea ...

Leading brokerage firms have shared their latest investment insights on IndusInd Bank, Marico, and Sun Pharma, highlighting key developments that could impact their stock performance for the next 12 ...

Sun Pharmaceutical Industries on Monday announced a definitive agreement to acquire Checkpoint Therapeutics for an upfront cash payment of $355 million (around Rs 3,099.51 crore). The company is ...

Shares of Trent, Sun Pharma, ICICI Bank, Bharti Airtel and BPCL topped the list of gainers among Nifty 50 pack, while IndusInd, Infosys, Bajaj Finserv, M&M and Wipro depreciated. Realty stocks ...

Knight Therapeutics Inc. GUD-T has signed a deal to buy the assets of Paladin Pharma Inc. as the Canadian drug company looks to build out its domestic business after a strategic push into South ...

Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of $355 million, or $4.10 per share, the companies said Sunday. With Unloxcyt, an FDA-approved PD-L1 therapy for ...

MUMBAI, India and WALTHAM, Mass., March 9, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE ...

March 10 (Reuters) - India's Sun Pharmaceutical Industries (SUN.NS), opens new tab said on Monday it will acquire Checkpoint Therapeutics (CKPT.O), opens new tab, a U.S.-based immunotherapy and ...

Hampton was appointed by the Justice Department in 2019 to represent the financial interests of victims in the Purdue Pharma bankruptcy case. For two years, he served on a committee of creditors.

Financial giants have made a conspicuous bullish move on Teva Pharmaceutical Indus. Our analysis of options history for Teva Pharmaceutical Indus (NYSE:TEVA) revealed 8 unusual trades. Delving ...